WELLINGTON MANAGEMENT GROUP LLP - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 145 filers reported holding CTI BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$12,690,544
-23.5%
3,021,558
+9.5%
0.00%0.0%
Q4 2022$16,581,006
+1.0%
2,758,903
-2.2%
0.00%0.0%
Q3 2022$16,410,000
+79.2%
2,819,663
+83.9%
0.00%
+50.0%
Q2 2022$9,155,000–1,533,470–0.00%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q4 2022.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders